Atlas Trials

Pluristem Ltd.

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Pluristem Ltd.

RecordFirmDate
Open-label Phase I Study for PEP or Treatment of HS-ARS PLX-R18 for the Post-Exposure Prevention (PEP) or Treatment of Hematopoietic Syndrome of Acute Radiation Syndrome (HS-ARS) (NCT03797040)Pluristem Ltd.2021-01-01
Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19 (NCT04614025)Pluristem Ltd.2020-10-19
Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 (NCT04389450)Pluristem Ltd.2020-10-01
Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF) (NCT03451916)Pluristem Ltd.2018-07-26

Track Pluristem Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.